The meeting brought together researchers, microbiologists and public health experts to discuss how public health can benefit from the recent scientific and technological advances in molecular microbiology, with special focus on the rapidly evolving next generation sequencing technology.
On the 22 November 2011, ECDC organised a workshop at the European Parliament to provide policy makers with more information on the facts about seasonal influenza vaccination and on ECDC’s contributions to the implementation of the 2009 Council Recommendation on this subject.
The launch event of the fourth European Antibiotic Awareness Day took place in Brussels and will follow the Commissioners’ Midday Press Briefing, where Commissioners Dalli presented the European Commission’s Action Plan to tackle Antimicrobial Resistance (AMR).
On the occasion of the fourth annual European Antibiotic Awareness Day (EAAD), ECDC is releasing new European-wide surveillance data showing that the percentage of carbapenem-resistant Klebsiella pneumoniae is increasing the European Union. Several Member States are now reporting that between 15 percent and almost 50 percent of K. pneumoniae from bloodstream infections are resistant to carbapenems. Carbapenems are the major last-line class of antibiotics to treat infections with multidrug-resistant Gram-negative bacteria such as Klebsiella pneumoniae, a frequent cause of pneumonia and urinary tract infections in hospitals.
On the occasion of the 4th European Antibiotic Awareness Day, ECDC releases new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Looking at finished and ongoing modelling projects sponsored by ECDC and other EU funders such ad DG Research and the Public Health Programme.2) Discussing what European Union mechanisms for communicable disease modelling networking would be useful in the future.